EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Public acceptance of genome editing in Saudi Arabia is driven by therapeutic benefit despite limited awareness

Hala Aldahshan, Tourkiah Alessa, Tahani O Alkahtani, Abeer Al-Hubaysh, Hamood AlSudais, Sana Saeed Alqarni, Nahla Bakhamis

Frontiers in Medicine · 25.06.2026 · 13

DOI: 10.3389/fmed.2026.1827655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 25.06.2026. Verfasst von Hala Aldahshan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome editing technologies are transforming precision medicine and rare disease therapeutics; however, their responsible clinical integration depends on public awareness, ethical acceptance, and trust in regulatory oversight. Evidence from culturally diverse populations remains limited, particularly in regions undergoing rapid investment in genomic medicine. A large nationwide cross-sectional survey was conducted using a structured, self-administered electronic questionnaire distributed to adults aged 18 years and older. The instrument assessed demographic characteristics, awareness of genome editing, perceived benefits and risks, ethical concerns, and acceptance of genome editing applications. Descriptive statistics, correlation analyses, and regression analyses were performed to examine factors associated with acceptance. A total of 1,712 participants completed the survey. Fewer than half of respondents reported prior awareness of genome editing, indicating limited baseline familiarity. Support for therapeutic applications was high, particularly when interventions were framed as treatments for serious or life-threatening conditions. Favourable attitudes and perceived clinical benefit were strongly associated with acceptance, while perceived risk demonstrated a modest negative association. Greater awareness was associated with increased ethical caution. Trust in national regulatory frameworks significantly strengthened confidence in gene therapy applications. These findings indicate a relatively supportive public perspective toward therapeutic genome editing in Saudi Arabia, particularly when its use is framed within appropriate ethical and regulatory boundaries. By providing population level evidence from an underrepresented region undergoing rapid genomic development, this study offers insights that may inform culturally responsive policy, public engagement, and responsible clinical translation of genome editing technologies.

Schlagwörter

Stichwörter der Autor:innen

CRISPR technologiesbioethicsethical acceptancegenome editinghuman genomicspublic awareness

Autor:innen und Institutionen

  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
  • Department of Biomedical Technology, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
  • Department of Radiological Sciences, College of Health and Rehabilitation Sciences, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Department of Biology, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.

Förderung

  • Deanship of Scientific Research at King Saud University

Zitieren

APA

Aldahshan, H., Alessa, T., Alkahtani, T. O., Al-Hubaysh, A., AlSudais, H., Alqarni, S. S., & Bakhamis, N. (2026). Public acceptance of genome editing in Saudi Arabia is driven by therapeutic benefit despite limited awareness. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1827655

Vancouver

Aldahshan H, Alessa T, Alkahtani TO, Al-Hubaysh A, AlSudais H, Alqarni SS, et al. Public acceptance of genome editing in Saudi Arabia is driven by therapeutic benefit despite limited awareness. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1827655

BibTeX
@article{Aldahshan2026,
  author = {Aldahshan, Hala and Alessa, Tourkiah and Alkahtani, Tahani O and Al-Hubaysh, Abeer and AlSudais, Hamood and Alqarni, Sana Saeed and Bakhamis, Nahla},
  title = {Public acceptance of genome editing in Saudi Arabia is driven by therapeutic benefit despite limited awareness},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1827655}
}
Kostenlos starten →